Liminatus Pharma Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Liminatus Pharma Inc.
Former names
Iris Parent Holding Corp.
Ownership
Public
Status
Active
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Cerritos
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
LIMN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001971387

Board of directors

Follow this board

Chief executives

Chris Kim · Chief Executive Officer
Since April 2025

Director election results

Annual meeting of August 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

1 of this board's directors also sit on 2 other boards.

Network of Liminatus Pharma Inc.'s board connections JATT II Acquisition Corp JATT II Acquisition Co... JATT III Acquisition Corp JATT III Acquisition C... Nicholas Fernandez Nicholas Fernandez Liminatus Pharma Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jul 2, 2026 Chris Kim Director, Officer (Chief Executive Officer), 10% owner Other +3,448,926 — —
Jun 24, 2026 Chris Kim Director, Officer (Chief Executive Officer), 10% owner Other −4,373,603 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.